A new study published in the journal of BMC Nephrology showed that hemodialysis patients with end-stage renal disease (ESRD) ...

Atrial fibrillation is relatively common in patients with chronic aortic regurgitation and is associated with an elevated ...

For patients with heart failure and severe mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair (M-TEER), ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...

AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a ...

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

Researchers developed an AI-powered ECG model, EchoNext, that detects structural heart disease with high accuracy across ...

The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...